This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by McDermott, P. F.
Right arrow Articles by Walker, R. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by McDermott, P. F.
Right arrow Articles by Walker, R. D.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, December 2001, p. 4283-4287, Vol. 39, No. 12
0095-1137/01/$04.00+0   DOI: 10.1128/JCM.39.12.4283-4287.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.

Standardization of Broth Microdilution and Disk Diffusion Susceptibility Tests for Actinobacillus pleuropneumoniae and Haemophilus somnus: Quality Control Standards for Ceftiofur, Enrofloxacin, Florfenicol, Gentamicin, Penicillin, Tetracycline, Tilmicosin, and Trimethoprim-Sulfamethoxazole

P. F. McDermott,1 A. L. Barry,2 R. N. Jones,3 G. E. Stein,4 C. Thornsberry,5 C. C. Wu,6 and R. D. Walker1,*

Division of Animal and Food Microbiology, Center for Veterinary Medicine, U.S. Food and Drug Administration, Laurel, Maryland1; The Clinical Microbiology Institute, Wilsonville, Oregon2; The Jones Group/JMI Laboratories, North Liberty, Iowa3; Department of Medicine, Michigan State University, East Lansing, Michigan4; MRL Pharmaceutical Services, Brentwood, Tennessee5; and Department of Veterinary Pathobiology, Purdue University, West Lafayette, Indiana6

Received 6 June 2001/Accepted 17 September 2001

Quality control (QC) standards for the in vitro antimicrobial susceptibility testing of two fastidious veterinary pathogens, Actinobacillus pleuropneumoniae and Haemophilus somnus, were developed in a multilaboratory study according to procedures established by the National Committee for Clinical Laboratory Standards for broth microdilution and disk diffusion testing. The medium recommended for the broth microdilution testing is cation-adjusted Mueller-Hinton broth supplemented with 2% lysed horse blood, 2% yeast extract, and 2% supplement C. This medium has been designated veterinary fastidious medium. The medium recommended for the disk diffusion testing is chocolate Mueller-Hinton agar. The recommended QC organisms are A. pleuropneumoniae ATCC 27090 and H. somnus ATCC 700025. The QC MICs of ceftiofur, enrofloxacin, florfenicol, gentamicin, penicillin, tetracycline, tilmicosin, and trimethoprim-sulfamethoxazole were determined for each isolate, as were the zone size ranges. Of the results from the participating laboratories, 94.0% of the zone diameter results and 97.0% of the MIC results fell within the suggested QC ranges for all compounds. These QC guidelines should allow greater accuracy in interpreting results when testing these antimicrobial agents against fastidious pathogens.


* Corresponding author. Mailing address: U.S. Food and Drug Administration, Center for Veterinary Medicine, HFV530, Laurel, MD 20708. Phone: (301) 827-8019. Fax: (301) 827-8250. E-mail: rwalker{at}cvm.fda.gov.


Journal of Clinical Microbiology, December 2001, p. 4283-4287, Vol. 39, No. 12
0095-1137/01/$04.00+0   DOI: 10.1128/JCM.39.12.4283-4287.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.



This article has been cited by other articles:

  • Priebe, S., Schwarz, S. (2003). In Vitro Activities of Florfenicol against Bovine and Porcine Respiratory Tract Pathogens. Antimicrob. Agents Chemother. 47: 2703-2705 [Abstract] [Full Text]